Skip to content
Trial Eligibility
Menu

ACUTE-GO is a Study Testing the Effectiveness and Safety of Two Doses of Purified Cortrophin Gel in Patients With Acute Gouty Arthritis Flares

NCT07938164

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

The goal of this clinical trial is to learn if Purified Cortrophin Gel can help people with acute gouty arthritis when they are having a sudden flare-up. It will also monitor participants for any potential side effects while on this therapy. The main question it aims to answer is: is there a change in gout pain intensity after receiving Purified Cortrophin Gel. Researchers will compare two different doses of Purified Cortrophin Gel.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Acute Gouty Arthritis

Eligibility basics and study details

Study type
Interventional
Phase
Phase 4
Ages
18 to 90 years
Sex
All
Healthy volunteers
Not accepted
Sponsor
ANI Pharmaceuticals
Last updated on ClinicalTrials.gov
November 16, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Massachusetts · 1

  • Mass General Hospital · Boston, MA

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.